These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 27695081)

  • 1. Structural Basis of Mucopolysaccharidosis Type II and Construction of a Database of Mutant Iduronate 2-Sulfatases.
    Saito S; Ohno K; Okuyama T; Sakuraba H
    PLoS One; 2016; 11(10):e0163964. PubMed ID: 27695081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular diagnosis of 65 families with mucopolysaccharidosis type II (Hunter syndrome) characterized by 16 novel mutations in the IDS gene: Genetic, pathological, and structural studies on iduronate-2-sulfatase.
    Kosuga M; Mashima R; Hirakiyama A; Fuji N; Kumagai T; Seo JH; Nikaido M; Saito S; Ohno K; Sakuraba H; Okuyama T
    Mol Genet Metab; 2016 Jul; 118(3):190-197. PubMed ID: 27246110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of Hunter syndrome (mucopolysaccharidosis type II) in Taiwanese: biochemical and linkage studies of the iduronate-2-sulfatase gene defects in MPS II patients and carriers.
    Lin SP; Chang JH; Lee-Chen GJ; Lin DS; Lin HY; Chuang CK
    Clin Chim Acta; 2006 Jul; 369(1):29-34. PubMed ID: 16480701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and clinical implications of amino acid substitutions in N-acetylgalactosamine-4-sulfatase: insight into mucopolysaccharidosis type VI.
    Saito S; Ohno K; Sugawara K; Sakuraba H
    Mol Genet Metab; 2008 Apr; 93(4):419-25. PubMed ID: 18248830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extension of the molecular analysis to the promoter region of the iduronate 2-sulfatase gene reveals genomic alterations in mucopolysaccharidosis type II patients with normal coding sequence.
    Brusius-Facchin AC; Abrahão L; Schwartz IV; Lourenço CM; Santos ES; Zanetti A; Tomanin R; Scarpa M; Giugliani R; Leistner-Segal S
    Gene; 2013 Sep; 526(2):150-4. PubMed ID: 23707223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic analysis of 17 children with Hunter syndrome: identification and functional characterization of four novel mutations in the iduronate-2-sulfatase gene.
    Chistiakov DA; Kuzenkova LM; Savost'anov KV; Gevorkyan AK; Pushkov AA; Nikitin AG; Vashakmadze ND; Zhurkova NV; Podkletnova TV; Namazova-Baranova LS; Baranov AA
    J Genet Genomics; 2014 Apr; 41(4):197-203. PubMed ID: 24780617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and clinical implications of amino acid substitutions in α-L-iduronidase: insight into the basis of mucopolysaccharidosis type I.
    Saito S; Ohno K; Maita N; Sakuraba H
    Mol Genet Metab; 2014 Feb; 111(2):107-12. PubMed ID: 24480078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Hunter disease (mucopolysaccharidosis type II) mutations on molecular phenotypes of iduronate-2-sulfatase: enzymatic activity, protein processing and structural analysis.
    Sukegawa-Hayasaka K; Kato Z; Nakamura H; Tomatsu S; Fukao T; Kuwata K; Orii T; Kondo N
    J Inherit Metab Dis; 2006 Dec; 29(6):755-61. PubMed ID: 17091340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and Functional Characterization of
    Lin HY; Tu RY; Chern SR; Lo YT; Fran S; Wei FJ; Huang SF; Tsai SY; Chang YH; Lee CL; Lin SP; Chuang CK
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31877959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic analysis of 63 Chinese patients with mucopolysaccharidosis type II: Functional characterization of seven novel IDS variants.
    Zhang W; Xie T; Sheng H; Shao Y; Lin Y; Jiang M; Xu A; Su X; Liu Z; Zhao X; Liu L; Huang Y
    Clin Chim Acta; 2019 Apr; 491():114-120. PubMed ID: 30639582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational spectrum of the iduronate-2-sulfatase (IDS) gene in 36 unrelated Russian MPS II patients.
    Karsten S; Voskoboeva E; Tishkanina S; Pettersson U; Krasnopolskaja X; Bondeson ML
    Hum Genet; 1998 Dec; 103(6):732-5. PubMed ID: 9921913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular investigations of a novel iduronate-2-sulfatase mutant in a Chinese patient.
    Lau KC; Lam CW
    Clin Chim Acta; 2008 Jun; 392(1-2):8-10. PubMed ID: 18331837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular analysis of the iduronate-2-sulfatase gene in Thai patients with Hunter syndrome.
    Keeratichamroen S; Cairns JR; Wattanasirichaigoon D; Wasant P; Ngiwsara L; Suwannarat P; Pangkanon S; Kuptanon J; Tanpaiboon P; Rujirawat T; Liammongkolkul S; Svasti J
    J Inherit Metab Dis; 2008 Dec; 31 Suppl 2():S303-11. PubMed ID: 18500569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mutational spectrum of hunter syndrome reveals correlation between biochemical and clinical profiles in Tunisian patients.
    Chkioua L; Grissa O; Leban N; Gribaa M; Boudabous H; Turkia HB; Ferchichi S; Tebib N; Laradi S
    BMC Med Genet; 2020 May; 21(1):111. PubMed ID: 32448126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis of iduronate-2-sulphatase gene mutations in patients with mucopolysaccharidosis type II (Hunter syndrome).
    Li P; Bellows AB; Thompson JN
    J Med Genet; 1999 Jan; 36(1):21-7. PubMed ID: 9950361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and structure characterization of novel IDS variants causing mucopolysaccharidosis type II: A retrospective analysis of 30 Chinese children.
    Zhao XY; Qiao GM; Liu F
    Clin Chim Acta; 2021 Dec; 523():386-394. PubMed ID: 34670126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of 40 Italian patients with mucopolysaccharidosis type II: New mutations in the iduronate-2-sulfatase (IDS) gene.
    Filocamo M; Bonuccelli G; Corsolini F; Mazzotti R; Cusano R; Gatti R
    Hum Mutat; 2001 Aug; 18(2):164-5. PubMed ID: 11462244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of 20 novel pathogenic variants in 60 unrelated Indian patients with mucopolysaccharidoses type I and type II.
    Uttarilli A; Ranganath P; Matta D; Md Nurul Jain J; Prasad K; Babu AS; Girisha KM; Verma IC; Phadke SR; Mandal K; Puri RD; Aggarwal S; Danda S; Sankar VH; Kapoor S; Bhat M; Gowrishankar K; Hasan AQ; Nair M; Nampoothiri S; Dalal A
    Clin Genet; 2016 Dec; 90(6):496-508. PubMed ID: 27146977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of 11 novel mutations in 49 Korean patients with mucopolysaccharidosis type II.
    Sohn YB; Ki CS; Kim CH; Ko AR; Yook YJ; Lee SJ; Kim SJ; Park SW; Yeau S; Kwon EK; Han SJ; Choi EW; Lee SY; Kim JW; Jin DK
    Clin Genet; 2012 Feb; 81(2):185-90. PubMed ID: 21291454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucopolysaccharidosis type II in a female patient with a reciprocal X;9 translocation and skewed X chromosome inactivation.
    Lonardo F; Di Natale P; Lualdi S; Acquaviva F; Cuoco C; Scarano F; Maioli M; Pavone LM; Di Gregorio G; Filocamo M; Scarano G
    Am J Med Genet A; 2014 Oct; 164A(10):2627-32. PubMed ID: 25044788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.